332
Views
31
CrossRef citations to date
0
Altmetric
Original Articles

31-Day Study of Cobalt(II) Chloride Ingestion in Humans: Pharmacokinetics and Clinical Effects

, , , , , & show all
Pages 1210-1224 | Published online: 27 Nov 2013

REFERENCES

  • 2004 . “ Agency for Toxic Substances and Disease Registry ” . In Toxicological profile for cobalt , Atlanta , GA : U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry .
  • Alexander , C. S. 1969 . Cobalt and the heart . Ann. Intern. Med , 70 : 411 – 413 .
  • Alexander , C. S. 1972 . Cobalt-beer cardiomyopathy: A clinical and pathologic study of twenty-eight cases . Am. J. Med , 53 : 395 – 417 .
  • Alimonti , A. , Bocca , B. , Mannella , E. , Petrucci , F. , Zennaro , F. , Cotichini , R. , D'Ippolito , C. , Agresti , A. , Caimi , S. and Forte , G. 2005 . Assessment of reference values for selected elements in a healthy urban population . Ann. Ist. Super. Sanita , 41 : 181 – 187 .
  • Anderson , M. B. , Pedigo , N. G. , Katz , R. P. and George , W. J. 1992 . Histopathology of testes from mice chronically treated with cobalt . Reprod. Toxicol , 6 : 41 – 50 .
  • Ayala-Fierro , F. , Firriolo , J. M. and Carter , D. E. 1999 . Disposition, toxicity, and intestinal absorption of cobaltous chloride in male Fischer 344 rats . J. Toxicol. Environ. Health A , 56 : 571 – 591 .
  • Barceloux , D. 1999 . Cobalt . Clin. Toxicol , 37 : 201 – 216 .
  • Bowie , E. A. and Hurley , P. J. 1975 . Cobalt chloride in the treatment of refractory anaemia in patients undergoing long-term haemodialysis . Aust. N. Z. J. Med , 5 : 306 – 314 .
  • Cable , R. G. , Glynn , S. A. , Kiss , J. E. , Mast , A. E. , Steele , W. R. , Murphy , E. L. , Wright , D. J. , Sacher , R. A. , Gottschall , J. L. , Vij , V. and Simon , T. L. 2011 . Iron deficiency in blood donors: Analysis of enrollment data from the REDS-II Donor Iron Status Evaluation (RISE) study . Transfusion (Paris) , 51 : 511 – 522 .
  • Christensen , J. M. , Poulsen , O. M. and Thomsen , M. 1993 . A short-term cross-over study on oral administration of soluble and insoluble cobalt compounds: Sex differences in biological levels . Int. Arch. Occup. Environ. Health , 65 : 233 – 240 .
  • Daniel , J. , Ziaee , H. , Pradhan , C. and McMinn , D. J. 2009 . Six-year results of a prospective study of metal ion levels in young patients with metal-on-metal hip resurfacings . J. Bone Joint Surg. Br , 91 : 176 – 179 .
  • Desert Rain Nutrition. 2012. Liquid ionic angstrom cobalt. Silt, CO: Desert Rain Nutrition. http://www.desertrainnutrition.com/index.php?main_page=product_info&cPath=1_8&products_id=192 (http://www.desertrainnutrition.com/index.php?main_page=product_info&cPath=1_8&products_id=192) (Accessed: 19 January 2012 ).
  • Discount Remedies, Inc. 2011. Cobalt supplement, ionic mineral supplement, 60 day supply–8 oz., MineralLife: Product description and supplement facts. Casper, WY: Discount Remedies, Inc. http://www.discountremediesinc.com/ionic-mineral-cobalt-supplement-8-oz.html (http://www.discountremediesinc.com/ionic-mineral-cobalt-supplement-8-oz.html) (Accessed: 5 January 2011 ).
  • Duckham , J. M. and Lee , H. A. 1976 . The treatment of refractory anaemia of chronic renal failure with cobalt chloride . Q. J. Med , 45 : 277 – 294 .
  • Elinder , C. G. 1984 . Health hazards from exposure to cobalt with special reference to carcinogenic, mutagenic and teratogenic effects . Toxicol Environ Chem , 7 : 251 – 256 .
  • European Chemicals Agency. 2013. Registered substances. http://echa.europa.eu/web/guest/information-on-chemicals/registered-substances (http://echa.europa.eu/web/guest/information-on-chemicals/registered-substances) (Accessed: 12 July 2013 ).
  • European Food Safety Authority . 2009 . Scientific opinion on the use of cobalt compounds as additives in animal nutrition . EFSA J , 7 : 1 – 45 .
  • 2003 . “ Expert Group on Vitamins and Minerals ” . In Safe upper levels for vitamins and minerals , London : Food Standards Agency .
  • Finch , C. A. , Cook , J. D. , Labbe , R. F. and Culala , M. 1977 . Effect of blood donation on iron stores as evaluated by serum ferritin . Blood , 50 : 441 – 447 .
  • Finley , B. L. , Monnot , A. D. , Gaffney , S. H. and Paustenbach , D. J. 2012a . Dose-response relationships for blood cobalt concentrations and health effects: A review of the literature and application of a biokinetic model . J. Toxicol. Environ. Health B , 15 : 493 – 523 .
  • Finley , B. L. , Monnot , A. D. , Paustenbach , D. J. and Gaffney , S. H. 2012b . Derivation of a chronic oral reference dose for cobalt . Regul. Toxicol. Pharmacol , 64 : 491 – 503 .
  • Firriolo , J. M. , Ayala-Fierro , F. , Sipes , I. G. and Carter , D. E. 1999 . Absorption and disposition of cobalt naphthenate in rats after a single oral dose . J. Toxicol. Environ. Health A , 58 : 383 – 395 .
  • Gardner , F. H. 1953 . The use of cobaltous chloride in the anemia associated with chronic renal disease . J. Lab. Clin. Med , 41 : 56 – 64 .
  • Glader , B. 2004 . “ Destruction of erythrocytes ” . In Wintrobe's clinical hematology. Volume 1 , 11th , Edited by: Wintrobe , M. M. and Greer , J. P. 249 – 265 . Philadelphia , PA : Lippincott Williams & Wilkins .
  • Gross , R. T. , Kriss , J. P. and Spaet , T. H. 1955 . The hematopoietic and goitrogenic effects of cobaltous chloride in patients with sickle cell anemia . Pediatrics , 15 : 284 – 290 .
  • Haga , Y. , Cline , N. , Hatori , N. , Hoffmann-Bang , C. , Pehrsson , S. K. and Ryden , L. 1996 . Impaired myocardial function following chronic cobalt exposure in an isolated rat heart model . Trace Elem. Electrolyt , 13 : 69 – 74 .
  • Harp , M. J. and Scoular , F. I. 1952 . Cobalt metabolism of young college women on self-selected diets . J. Nutr , 47 : 67 – 72 .
  • Hokin , B. , Adams , M. , Ashton , J. and Louie , H. 2004 . Comparison of the dietary cobalt intake in three different Australian diets . Asia Pac. J. Clin. Nutr , 13 : 289 – 291 .
  • Kerger , B. D. , Gerads , R. , Gurleyuk , H. , Thuett , K. A. , Finley , B. L. and Paustenbach , D. J. 2013a . Cobalt speciation assay for human serum. Part I. Method for measuring large and small molecular cobalt and albumin-binding capacity using size exclusion chromatography with inductively-coupled plasma-mass spectroscopy detection . Toxicol. Environ. Chem , 95 : 687 – 708 .
  • Kerger , B. D. , Tvermoes , B. , Unice , K. , Finley , B. L. , Paustenbach , D. J. and Galbraith , D. 2013b . Cobalt speciation assay for human serum. Part II. Method validation in a study of human volunteers ingesting cobalt(II) chloride dietary supplement for 90 days . Toxicol. Environ. Chem , 95 : 709 – 718 .
  • Kriss , J. P. , Carnes , W. H. and Gross , R. T. 1955 . Hypothyroidism and thyroid hyperplasia in patients treated with cobalt . J. Am. Med. Assoc , 157 : 117 – 121 .
  • Leggett , R. W. 2008 . The biokinetics of inorganic cobalt in the human body . Sci. Total Environ , 389 : 259 – 269 .
  • Licht , A. , Oliver , M. and Rachmilewitz , E. A. 1972 . Optic atrophy following treatment with cobalt chloride in a patient with pancytopenia and hypercellular marrow . Isr. J. Med. Sci , 8 : 61 – 66 .
  • Mahida , V. I. , Bhatti , A. and Gupte , S. C. 2008 . Iron status of regular voluntary blood donors . Asian J. Transfus. Sci , 2 : 9 – 12 .
  • Meltzer , H. M. , Brantsaeter , A. L. , Borch-Iohnsen , B. , Ellingsen , D. G. , Alexander , J. , Thomassen , Y. , Stigum , H. and Ydersbond , T. A. 2010 . Low iron stores are related to higher blood concentrations of manganese, cobalt and cadmium in non-smoking, Norwegian women in the HUNT 2 study . Environ. Res , 110 : 497 – 504 .
  • Minoia , C. , Sabbioni , E. , Apostoli , P. , Pietra , R. , Pozzoli , L. , Gallorini , M. , Nicolaou , G. , Alessio , L. and Capodaglio , E. 1990 . Trace element reference values in tissues from inhabitants of the European community. I. A study of 46 elements in urine, blood and serum of Italian subjects . Sci. Total Environ , 95 : 89 – 105 .
  • Mohiuddin , S. M. , Taskar , P. K. , Rheault , M. , Roy , P. E. , Chenard , J. and Morin , Y. 1970 . Experimental cobalt cardiomyopathy . Am. Heart J , 80 : 532 – 543 .
  • Morin , Y. , Tetu , A. and Mercier , G. 1971 . Cobalt cardiomyopathy: Clinical aspects . Br. Heart J , 33 : 175 – 178 .
  • Moshtaghie , A. A. , Badii , A. and Mohammadian , T. 2004 . The comparative study of binding characteristics of cobalt and iron to human serum transferrin . J. Res. Med. Sci , 9 : 250 – 254 .
  • Mother Earth Minerals, Inc. 2011. Cobalt. Ogden, UT: Mother Earth Minerals, Inc. http://www.meminerals.com/catalog/ProductDetails.asp?ProductID=MINE4S00XEI8Co&DealerID=&Express=1 (http://www.meminerals.com/catalog/ProductDetails.asp?ProductID=MINE4S00XEI8Co&DealerID=&Express=1) (Accessed: 5 January 2011 ).
  • Nation , J. R. , Bourgeois , A. E. , Clark , D. E. and Hare , M. F. 1983 . The effects of chronic cobalt exposure on behavior and metallothionein levels in the adult rat . Neurobehav. Toxicol. Teratol , 5 : 9 – 15 .
  • Newman , B. H. 2004 . Blood donor complications after whole-blood donation . Curr. Opin. Hematol , 11 : 339 – 345 .
  • Oettl , K. and Stauber , R. E. 2007 . Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties . Br. J. Pharmacol , 151 : 580 – 590 .
  • Onkelinx , C. 1976 . Compartment analysis of cobalt(II) metabolism in rats of various ages . Toxicol. Appl. Pharmacol , 38 : 425 – 438 .
  • Patty , F. A. , Fassett , D. W. and Irish , D. D. 1962 . “ The metals ” . In Industrial hygiene and toxicology. Volume II: Toxicology , 2nd , 1132 – 1194 . New York , NY : Wiley .
  • Paustenbach , D. J. , Tvermoes , B. E. , Unice , K. M. , Finley , B. L. and Kerger , B. D. 2013a . A review of the health hazards posed by cobalt . Crit. Rev. Toxicol , 43 : 316 – 362 .
  • Paustenbach, D. J., Galbraith, D. A., and Finley, B. L. 2013b. Interpreting cobalt blood concentrations in hip implant patients. 2013. Clin Toxicol. DOI: 10.3109/15563650.2013.857024.
  • Pedigo , N. G. , George , W. J. and Anderson , M. B. 1988 . Effects of acute and chronic exposure to cobalt on male reproduction in mice . Reprod. Toxicol , 2 : 45 – 53 .
  • Reuber , S. , Kreuzer , M. and Kirchgessner , M. 1994 . Interactions of cobalt and iron in absorption and retention . J. Trace Elem. Electrolytes Health Dis , 8 : 151 – 158 .
  • Rohn , R. J. and Bond , W. H. 1953 . Observations on some hematological effects of cobalt-iron mixtures . Lancet , 73 : 317 – 324 .
  • Sandusky , G. E. , Crawford , M. P. and Roberts , E. D. 1981 . Experimental cobalt cardiomyopathy in the dog: A model for cardiomyopathy in dogs and man . Toxicol. Appl. Pharmacol , 60 : 263 – 278 .
  • Sederholm , T. , Kouvalainen , K. and Lamberg , B. A. 1968 . Cobalt-induced hypothyroidism and polycythemia in lipoid nephrosis . Acta Med. Scand , 184 : 301 – 306 .
  • Simon , T. L. , Garry , P. J. and Hooper , E. M. 1981 . Iron stores in blood donors . J. Am. Med. Assoc , 245 : 2038 – 2043 .
  • Simonsen , L. O. , Brown , A. M. , Harbak , H. , Kristensen , B. I. and Bennekou , P. 2011a . Cobalt uptake and binding in human red blood cells . Blood Cells Mol. Dis , 46 : 266 – 276 .
  • Simonsen , L. O. , Harbak , H. and Bennekou , P. 2011b . Passive transport pathways for Ca(2+) and Co(2+) in human red blood cells. (57)Co(2+) as a tracer for Ca(2+) influx . Blood Cells Mol. Dis , 47 : 214 – 225 .
  • Simonsen , L. O. , Harbak , H. and Bennekou , P. 2012 . Cobalt metabolism and toxicology—A brief update . Sci. Total Environ , 432C : 210 – 215 .
  • Smith , T. , Edmonds , C. J. and Barnaby , C. F. 1972 . Absorption and retention of cobalt in man by whole-body counting . Health Phys , 22 : 359 – 367 .
  • Sorbie , J. , Olatunbosun , D. , Corbett , W. E. and Valberg , L. S. 1971 . Cobalt excretion test for the assessment of body iron stores . Can. Med. Assoc. J , 104 : 777 – 782 .
  • Stokinger , H. E. 1981 . “ The metals ” . In Patty's industrial hygiene and toxicology, Vol. II A: Toxicology , 3rd , Edited by: Patty , F. A. , Clayton , G. D. and Clayton , F. E. 1493 – 2060 . New York , NY : Wiley .
  • Taylor , A. , Marks , V. , Shabaan , A. A. , Mahmood , H. A. , Duckham , J. M. and Lee , H. A. 1977 . “ Cobalt-induced lipaemia and erythropoiesis ” . In Clinical chemistry and chemical toxicology of metals: Proceedings of the First International Symposium 105 – 108 . Monte Carlo, 2–5 March, 1977.
  • Taylor , D. M. 1962 . The absorption of cobalt from the gastrointestinal tract of the rat . Phys. Med. Biol , 6 : 445 – 451 .
  • Thomas , R. G. , Furchner , J. E. , London , J. E. , Drake , G. A. , Wilson , J. S. and Richmond , C. R. 1976 . Comparative metabolism of radionuclides in mammals—X. Retention of tracer-level cobalt in the mouse, rat, monkey and dog . Health Phys , 31 : 323 – 333 .
  • Tvermoes , B. E. , Finley , B. L. , Unice , K. M. , Otani , J. M. , Paustenbach , D. J. and Galbraith , D. A. 2013 . Cobalt whole blood concentrations in healthy adult male volunteers following two-weeks of ingesting a cobalt supplement . Food Chem. Toxicol , 53 : 432 – 439 .
  • Unice , K. , Monnot , A. , Gaffney , S. H. , Tvermoes , B. , Thuett , K. , Paustenbach , D. and Finley , B. 2012 . Inorganic cobalt supplementation: Prediction of cobalt levels in whole blood and urine using a biokinetic model . Food Chem. Toxicol , 50 : 2456 – 2461 .
  • 2008 . “ U.S. Environmental Protection Agency ” . In Provisional peer reviewed toxicity values for cobalt (CASRN 7440-48-4) , Cincinnati , OH : U.S. Environmental Protection Agency .
  • 2011 . “ U.S. Environmental Protection Agency ” . In Recommended use of body weight 3/4 as the default method in derivation of the oral reference dose. EPA/100/R11/00010 Final , Washington , DC : U.S. Environmental Protection Agency .
  • Valberg , L. S. , Ludwig , J. and Olatunbosun , D. 1969 . Alteration in cobalt absorption in patients with disorders of iron metabolism . Gastroenterology , 56 : 241 – 251 .
  • Wolf , J. and Levy , I. J. 1954 . Treatment of sickle cell anemia with cobalt chloride . Arch. Intern. Med , 93 : 387 – 396 .
  • 2006 . “ World Health Organization ” . In Cobalt and inorganic cobalt compounds. Concise international chemical assessment document: 69 , Geneva , Switzerland : World Health Organization .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.